Center for Head, Neck, and Skull Base Tumors
Articles from John G. Meara, MD, DMD, MBA
Frontoethmoidal Encephaloceles
Isolated and Syndromic Syngnathism
Articles from Reza Rahbar, DMD, MD, FACS
Acute Mastoiditis with temporomandibular joint effusion
Congenital absence of the incus bilaterally without other otologic anomalies.
Craniofacial, temporal bone, and audiologic abnormalities in the spectrum of hemifacial microsomia
Development and Maturation of the pediatric human vocal fold lamina propria
Endoscopic sinus surgery in cystic fibrosis
Fat implantation into the Reinke's space A histological and stroboscopic study in the canine
Lymphatic malformation of the lingual base and oral floor
Management of giant lymphatic malformation of the tongue
Mitomycin effects on laryngeal and tracheal stenosis benefits and complications
Mitomycin-C for the prevention of adhesion formation after endoscopic sinus surgery
Mucoepidermoid carcinoma of parotid gland in children
Nasal Glioma & Encephalocele Diagnosis and Management
Oropharyngeal Teratoma Prenatal diagnosis and assessment
Pleomorphic Adenoma of the parotid gland in children
The presentation and management of laryngeal clefts: A ten year experience
Radiofrequency ablation of microcystic lymphatic malformation in the oral cavity
Robin sequence A retrospective review of 115 patients
The role of vascular endothelial growth factor-A in recurrent respiratory papillomatosis
Management of orbital subperiosteal abscess in children
The presentation of lymphatic malformation of the cervicofacial region: Role of trauma
The presentation and management of nasal dermoid: A thirty year experience
The presentation and management of subglottic hemangioma: past, present, future
The biology and management of laryngeal neurofibroma
Robotic Surgery in the Pediatric Airway. Application and Safety
The presentation and management of vascular rings: An Otolaryngology perspective
The role of VEGF in airway stenosis
A new target for lymphoma therapy
Frederick Alt, PhD, and his team discovered that IgH3’RR is also responsible for the over-activation of c-myc that leads to lymphoma. They believe IgH3’RR may be a new target for drugs targeting Burkitt’s lymphoma, multiple myelomas and other blood-related cancers that originate in mature B cells. Dec. 10, Nature.